Oppenheimer & Co. Inc. Takes $1.29 Million Position in Axsome Therapeutics, Inc. $AXSM
MarketBeat
Oppenheimer & Co. Inc. purchased a new position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 7,076 shares of the company's stock, valued at approximately $1,292,
NASDAQ:AXSM